Physical Medicine & Rehabilitation · Saginaw, MI
NPI
1265517452
Since 2006
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4901 Towne Centre Rd, Ste 300
Saginaw, MI, 48604
Phone (989) 498-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,041 services
Medicare patients, 2024
157
Average age 65
Drug cost, 2024
$476K
9,989 prescriptions
Company payments, 2025
$36.71
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Laclair was code 99214 (office e&m - established), 513 times for 151 patients. In total Paul A Laclair billed 1,041 services in 18 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 513 | 151 | $73.68 | $38K |
| 80307 Drug Tests | Office | 215 | 110 | $59.26 | $13K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 176 | 98 | $194.77 | $34K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 54 | 11 | $0.68 | $36.56 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 19 | 19 | $153.46 | $2,916 |
By year: 2022 $136K for 1,470 services; 2023 $118K for 1,323 services; 2024 $91K for 1,041 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 215 | 110 | $59.26 | $13K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 176 | 98 | $194.77 | $34K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 19 | 19 | $153.46 | $2,916 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Laclair prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,381 prescriptions and refills. In total Paul A Laclair wrote 9,989 Medicare prescriptions that cost $476K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,381 | 2,388 | 276 | $40K |
| Gabapentin Generic | 1,030 | 1,541 | 185 | $21K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 860 | 861 | 101 | $18K |
| Morphine Sulfate Er Morphine Sulfate | 678 | 679 | 83 | $27K |
| Fentanyl Generic | 489 | 489 | 58 | $57K |
| Cyclobenzaprine Hcl Generic | 367 | 586 | 76 | $2,105 |
| Pregabalin Generic | 340 | 496 | 58 | $6,665 |
| Tizanidine Hcl Generic | 328 | 553 | 76 | $5,723 |
| Ibuprofen Generic | 277 | 423 | 62 | $3,013 |
| Tramadol Hcl Generic | 260 | 264 | 49 | $1,481 |
| Oxycodone Hcl Generic | 233 | 233 | 31 | $3,296 |
| Baclofen Generic | 171 | 235 | 34 | $2,287 |
| Meloxicam Generic | 169 | 293 | 39 | $660 |
| Methadone Hcl Generic | 161 | 161 | 25 | $2,221 |
| Duloxetine Hcl Generic | 154 | 285 | 35 | $3,450 |
Brand drugs: 430 claims; generic drugs: 9,559 claims; opioid claims: 5,755.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Laclair $36.71 ($36.71 in general payments such as food, travel and fees) from 1 company. The largest payer was Collegium Pharmaceutical, Inc. with $36.71.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 2 | $36.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.